Skip to content
HowShorted

Ocugen, Inc. short interest in 2023

In 2023, Ocugen, Inc.'s disclosed short interest ran from 20.37% of shares outstanding on 13 Jan 2023 to 9.17% on 29 Dec 2023, a change of -11.20 percentage points. The year's high was 23.24% on 15 Mar 2023 and its low 8.68% on 15 Dec 2023, averaging 14.27% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.30 days on 30 Nov 2023. Full history: Ocugen, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Ocugen, Inc. in 2023

2023 in figures

Start of year
20.37% (13 Jan 2023)
End of year
9.17% (29 Dec 2023)
Change
-11.20 pp
High
23.24% (15 Mar 2023)
Low
8.68% (15 Dec 2023)
Average
14.27%
Highest days to cover
23.30 (30 Nov 2023)
SEC filings marked
9

Every report in 2023

Ocugen, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202320.37%5.41
31 Jan 202320.55%9.56
15 Feb 202321.65%9.33
28 Feb 202322.60%7.2710-K filed, results (8-K)
15 Mar 202323.24%6.56
31 Mar 202316.95%4.26
14 Apr 202317.15%10.03
28 Apr 202317.64%7.10
15 May 202318.00%7.4410-Q filed, results (8-K)
31 May 202318.46%3.42
15 Jun 202316.45%4.55
30 Jun 202311.90%2.65
14 Jul 202311.22%4.59
31 Jul 202310.97%5.15
15 Aug 20239.62%6.64
31 Aug 20239.95%7.0010-Q filed, results (8-K), results (8-K)
15 Sep 20239.49%12.01
29 Sep 20239.83%14.36
13 Oct 20239.89%17.78
31 Oct 20239.63%17.56
15 Nov 20239.82%22.3710-Q filed, results (8-K)
30 Nov 20239.29%23.30
15 Dec 20238.68%17.41
29 Dec 20239.17%3.83

See also: Ocugen, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.